Drug Trial Radar · NCT06922110
An Open-Label Study of Azetukalner in Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
460
Planned (sponsor's estimate)
Start
Mar 18, 2025
Primary completion
Jan 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Xenon Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult participants who successfully completed an antecedent Phase 3 study of azetukalner in Major Depressive Disorder (MDD).
Conditions
- Major Depressive Disorder
Interventions
AzetukalnerDrug
Azetukalner 20 mg taken orally once a day with food (with the evening meal when possible) for 52 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Severity and frequency of treatment-emergent adverse events, serious adverse events, adverse events of special interest, and events of clinical interestTime frame: From the start of treatment in the open-label extension study through 8 weeks after the last dose
Locations
71 sites in 3 countries. Site status is shown where the registry gives one.
Ima Clinical Research - Phoenix
Phoenix, Arizona
Sanro Clinical Research Group, Llc
Bryant, Arkansas
Woodland International Research Group
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Cenexel Cit - Bellflower
Bellflower, California
Irvine Clinical Research
Irvine, California
Calneuro Research Group, Inc.
Los Angeles, California
Excell Research Inc.
Oceanside, California
Atp Clinical Research
Orange, California
Nrc Research Institute
Orange, California
Artemis Institute For Clinical Research - San Diego
San Diego, California
Cenexel Cnr - Sherman Oaks
Sherman Oaks, California
Cenexel Cns - Torrance
Torrance, California
Pacific Clinical Research Management
Upland, California
Sunwise Clinical Research
Walnut Creek, California
Ct Clinical Research Associates
Cromwell, Connecticut
Institute of Living - Clinical Trials Unit
Hartford, Connecticut
Pharmasouth Research
Coral Gables, Florida
Cns Clinical Research - Coral Springs
Coral Springs, Florida
Gulfcoast Clinical Research Center
Fort Myers, Florida
Sarkis Clinical Trials
Gainesville, Florida
Neoclinical Research
Hialeah, Florida
Clinical Neuroscience Solutions Llc.
Jacksonville, Florida
Accel Research Sites - Lakeland
Lakeland, Florida
Accel Research Sites - St. Petersburg-Largo
Largo, Florida
Harmony Clinical Research Inc
North Miami Beach, Florida
Clinical Neuroscience Solutions Llc
Orlando, Florida
Combined Research Orlando Phase I-Iv
Orlando, Florida
Panhandle Research and Medical Clinic
Pensacola, Florida
Equipath Health and Research Tampa Bay, Llc
Riverview, Florida
Advanced Discovery Research, Llc
Atlanta, Georgia
Synexus - Atlanta
Atlanta, Georgia
DelRicht Research
Atlanta, Georgia
Cenexel Iresearch - Atlanta
Decatur, Georgia
Psych Atlanta, Pc
Marietta, Georgia
Cenexel Iresearch - Savannah
Savannah, Georgia
IMA Clinical Research
Chicago, Illinois
Advanced Quality Medical Research, LLC
Orland Park, Illinois
Pharmasite Research Inc.
Baltimore, Maryland
Adams Clinical - Boston
Boston, Massachusetts
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.